BlackRock Institutional Trust’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$5.9M Buy
349,005
+54,405
+18% +$919K ﹤0.01% 2660
2016
Q3
$4.83M Buy
294,600
+25,613
+10% +$420K ﹤0.01% 2702
2016
Q2
$4.07M Buy
268,987
+35,386
+15% +$536K ﹤0.01% 2771
2016
Q1
$3.38M Buy
233,601
+52,341
+29% +$757K ﹤0.01% 2823
2015
Q4
$5.13M Buy
181,260
+17,261
+11% +$489K ﹤0.01% 2705
2015
Q3
$2.75M Buy
163,999
+46,312
+39% +$775K ﹤0.01% 2985
2015
Q2
$3.09M Buy
117,687
+87,918
+295% +$2.31M ﹤0.01% 2943
2015
Q1
$521K Buy
29,769
+5,776
+24% +$101K ﹤0.01% 3486
2014
Q4
$417K Sell
23,993
-651
-3% -$11.3K ﹤0.01% 3516
2014
Q3
$459K Sell
24,644
-5,233
-18% -$97.5K ﹤0.01% 3493
2014
Q2
$546K Buy
+29,877
New +$546K ﹤0.01% 3529